These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 31539351

  • 1. Two-center comparison of 10 fully-automated commercial procalcitonin (PCT) immunoassays.
    Lippi G, Salvagno GL, Gelati M, Pucci M, Lo Cascio C, Demonte D, Faggian D, Plebani M.
    Clin Chem Lab Med; 2019 Dec 18; 58(1):77-84. PubMed ID: 31539351
    [Abstract] [Full Text] [Related]

  • 2. Multicenter comparison of automated procalcitonin immunoassays.
    Dipalo M, Guido L, Micca G, Pittalis S, Locatelli M, Motta A, Bianchi V, Callegari T, Aloe R, Da Rin G, Lippi G.
    Pract Lab Med; 2015 Aug 01; 2():22-28. PubMed ID: 28932801
    [Abstract] [Full Text] [Related]

  • 3. Analytical evaluation of the performances of Diazyme and BRAHMS procalcitonin applied to Roche Cobas in comparison with BRAHMS PCT-sensitive Kryptor.
    Ceriotti F, Marino I, Motta A, Carobene A.
    Clin Chem Lab Med; 2017 Nov 27; 56(1):162-169. PubMed ID: 28809746
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of procalcitonin immunoassay concordance near clinical decision points.
    Chambliss AB, Hayden J, Colby JM.
    Clin Chem Lab Med; 2019 Aug 27; 57(9):1414-1421. PubMed ID: 30763263
    [Abstract] [Full Text] [Related]

  • 5. Concordance of Three Automated Procalcitonin Immunoassays at Medical Decision Points.
    Cho HW, Kim SH, Cho Y, Jeong SH, Lee SG.
    Ann Lab Med; 2021 Jul 01; 41(4):419-423. PubMed ID: 33536362
    [Abstract] [Full Text] [Related]

  • 6. Comparison of a novel automated DiaSys procalcitonin immunoassay with four different BRAHMS-partnered immunoassays.
    Eidizadeh A, Wiederhold M, Schnelle M, Binder L.
    Pract Lab Med; 2022 May 01; 30():e00274. PubMed ID: 35465623
    [Abstract] [Full Text] [Related]

  • 7. Comparison of the Siemens Atellica BRAHMS and the Abbott Architect BRAHMS Procalcitonin Assays.
    Walker C, Shuster A, Weber C, Gebhardt K, Scheidegger M, Swartzwelder J, Williams J, Li J.
    Ann Clin Lab Sci; 2021 Mar 01; 51(2):241-244. PubMed ID: 33941564
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Analytical evaluation of the novel Lumipulse G BRAHMS procalcitonin immunoassay.
    Ruzzenente O, Salvagno GL, Gelati M, Lippi G.
    Pract Lab Med; 2016 Dec 01; 6():8-13. PubMed ID: 28856208
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the Abbott Architect BRAHMS and the Biomérieux Vidas BRAHMS Procalcitonin Assays.
    Wang D, Caddell B, Nolte FS, Babic N.
    J Appl Lab Med; 2019 Jan 01; 3(4):580-586. PubMed ID: 31639727
    [Abstract] [Full Text] [Related]

  • 11. Analytical evaluation of the novel VITROS BRAHMS procalcitonin immunoassay.
    Dupuy AM, Bargnoux AS, Montagnon V, Kuster N, Badiou S, Cristol JP.
    Scand J Clin Lab Invest; 2020 Nov 01; 80(7):541-545. PubMed ID: 33124916
    [Abstract] [Full Text] [Related]

  • 12. Analytical and clinical performance of the Advansure i3 procalcitonin assay.
    Heo W, Park HD.
    Scand J Clin Lab Invest; 2021 Nov 01; 81(7):546-551. PubMed ID: 34601986
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the novel ARCHITECT procalcitonin assay with established procalcitonin assay systems.
    Soh A, Binder L, Clough M, Hernandez MH, Lefèvre G, Mostert K, Nguyen TB, Otte KM, Portakal O, Sandri MS, Yen JL, Huang J, Beshiri A.
    Pract Lab Med; 2018 Nov 01; 12():e00110. PubMed ID: 30519621
    [Abstract] [Full Text] [Related]

  • 14. As a Novel Procalcitonin Assay is Architect B∙R∙A∙H∙M∙S PCT; Comparison of Two Commercial Systems.
    Aydemir Ö, Karakeçe E, Köroğlu M, Aydemir Y, Terzi HA, Erkorkmaz Ü, Altindiş M.
    Clin Lab; 2019 Apr 01; 65(4):. PubMed ID: 30969065
    [Abstract] [Full Text] [Related]

  • 15. Comparison of Procalcitonin Assays on KRYPTOR and LIAISON® XL Analyzers.
    Dipalo M, Gnocchi C, Avanzini P, Musa R, Di Pietro M, Aloe R.
    Diagnostics (Basel); 2019 Aug 08; 9(3):. PubMed ID: 31398868
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of a fully automated procalcitonin chemiluminescence immunoassay.
    Hubl W, Krassler J, Zingler C, Pertschy A, Hentschel J, Gerhards-Reich C, Mack M, Demant T.
    Clin Lab; 2003 Aug 08; 49(7-8):319-27. PubMed ID: 12908732
    [Abstract] [Full Text] [Related]

  • 17. Differences in procalcitonin measurements between three BRAHMS-partnered immunoassays (Liaison, Elecsys and Architect).
    Eidizadeh A, Asif AR, von Ahsen N, Binder L, Schnelle M.
    Clin Chem Lab Med; 2019 Aug 27; 57(9):e207-e210. PubMed ID: 30325730
    [No Abstract] [Full Text] [Related]

  • 18. [Evaluation of procalcitonin assay on the Abbott Architect i2000 SR® analyzer].
    El Mouatani A, Rotaru I, Beaudeux JL, Hennequin C.
    Ann Biol Clin (Paris); 2018 Jun 01; 76(3):308-312. PubMed ID: 29622524
    [Abstract] [Full Text] [Related]

  • 19. Reply to: Analytical evaluation of the performances of Diazyme and BRAHMS procalcitonin applied to Roche Cobas in comparison with BRAHMS PCT-sensitive Kryptor.
    Yuan C.
    Clin Chem Lab Med; 2017 Nov 27; 56(1):e5-e6. PubMed ID: 29031019
    [No Abstract] [Full Text] [Related]

  • 20. Analytical Performance of the VIDAS® BRAHMS Procalcitonin Assay and Beckman Coulter Unicel® DXI Procalcitonin Assay in a Stat Laboratory.
    Chen GY, Chen SY, Er TK.
    Clin Lab; 2021 Mar 01; 67(3):. PubMed ID: 33739041
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.